Compliance Blog - R.J. Hedges & Associates

USP <800> Myth Busters!

[fa icon="calendar'] Thu, Nov 14, 2019 / by Jenny Schell posted in USP <800>

[fa icon="comment"] 3 Comments


“My wholesaler said, my state board of pharmacy said, my PSAO said, my area president said…”  We’ve been fielding a lot of questions regarding USP <800> compliance for almost a year now and one thing is for sure, pharmacists are getting mixed messages from various groups. 

With so  many people getting conflicting answers around when USP <800> goes into effect, who will be enforcing, and even the type of drugs; we wanted to bust the Top 5 Myths.

Read More [fa icon=long-arrow-right"]

Preparing the Hazardous Drugs Assessment of Risk

[fa icon="calendar'] Mon, Oct 28, 2019 / by Jeff Hedges posted in USP <800>

[fa icon="comment"] 1 Comment


This is our second part of our series on preparing for USP <800> Hazardous Drugs. On our last podcast, titled: Why will USP <800> Impact My Retail and LTC Pharmacy? We addressed what each pharmacy must do first in preparation for implementing this guideline. How to identify Hazardous Drugs through the NIOSH List, segregations and special handing and finally who is going to enforce these guidelines.

Read More [fa icon=long-arrow-right"]

5 Things to Consider Before Buying a Pharmacy

[fa icon="calendar'] Mon, Sep 16, 2019 / by Becky Templeton posted in Pharmacy

[fa icon="comment"] 2 Comments


The prospect of buying a pharmacy is enticing to pharmacists for a variety of reasons. The items at the top of the list are; freedom and responsibility of ownership, the chance to practice pharmacy on your own terms, do more to improve the health of your patients, and improve your earning potential.  These are all realistic goals when you have your own location, however, the process of purchasing can be complicated and lengthy regardless of how well prepared you are.

Read More [fa icon=long-arrow-right"]

How Will USP <800> Impact My Retail and LTC Pharmacy?

[fa icon="calendar'] Fri, Sep 13, 2019 / by Jeff Hedges posted in USP <800>

[fa icon="comment"] 3 Comments


A lot is happening in the pharmacy marketplace, including PBM reform and even massive layoffs. While a lot of this buzz might seem negative, there’s a feeling that positivity is on the way. Still, it’s crunch time for the pharmacy industry with USP <800> on the horizon.

Read More [fa icon=long-arrow-right"]

USP <800> It’s Not Just for Compounding Pharmacies

[fa icon="calendar'] Thu, Apr 18, 2019 / by Becky Templeton posted in USP <800>

[fa icon="comment"] 6 Comments


Are you starting to feel that the practice of pharmacy is like the Abbot and Costello sketch “Who’s on First”?  At every turn a new regulation is going into place; another merger of an insurer, chain, or healthcare system is occurring; some entity is auditing, inspecting, or reviewing your paperwork, files, and process; and someone new is dipping their hands into your pockets to take a little more of your reimbursements. Even with all those shenanigans going on, the biggest topic in pharmacy outside of DIR fees, is USP <800>USP <800> Hazardous Drugs Compliance for Retail Pharmacies

Read More [fa icon=long-arrow-right"]

How to Open an Independent Pharmacy

[fa icon="calendar'] Fri, Apr 12, 2019 / by Becky Templeton posted in Independent Pharmacy

[fa icon="comment"] 3 Comments

Opening a successful independent pharmacy is a challenging undertaking for any pharmacist, especially with the competitiveness of today’s retail pharmacy market. Building a new pharmacy from the ground up doesn’t guarantee foot traffic, and leasing or owning a property doesn’t mean you’re ready to open for business.

Read More [fa icon=long-arrow-right"]

How to Value an Independent Pharmacy

[fa icon="calendar'] Tue, Feb 19, 2019 / by Becky Templeton posted in Pharmacy Brokerage

[fa icon="comment"] 2 Comments

Although a pharmacy’s true value is determined by what a buyer is willing to pay for it, there are a number of factors that go into a valuation. Beyond that, valuations happen for a variety of reasons, including retirement planning, expanding a current business, or adding a location. Less fortunate examples include dissolving partnerships, a buyout or dispute, and settlements of assets or estates. Or, in the case of purchasing a pharmacy, a valuation helps determine if the asking price has merit.

Read More [fa icon=long-arrow-right"]

HIPAA BAA - Why the Business Associate Agreement May be Your Pharmacy's Most Important Piece of Paper

[fa icon="calendar'] Tue, Feb 12, 2019 / by Becky Templeton posted in HIPAA, Business Associate Agreement

[fa icon="comment"] 2 Comments


A colleague recently shared a news release about a physicians’ group that was hit with a $500,000 fine. The fine wasn’t a result of fraud, a misfiled prescription, or malpractice, as one might expect.  Instead, the physicians’ group simply failed to have business associate agreements in place. 

This led me to wonder two things.  First, how common is it for people to go through eight or more years of school to become a doctor without fully understanding HIPAA? And second, if practitioners realize the importance of protecting patients, do they understand what they can put in place to protect themselves as the practitioner?

Read More [fa icon=long-arrow-right"]

Staying off the OIG Naughty List

[fa icon="calendar'] Wed, Dec 19, 2018 / by Becky Templeton posted in Inspections

[fa icon="comment"] 0 Comments

RJ_Hedges-Christmas_Comic_Strip-120718This time of year, children are compiling Christmas wish lists, trying their hardest to stay on Santa’s “Nice List” and possibly doing extra things to move off the “Naughty List.” We’ve had a lot of questions lately about another Naughty List out there, the OIG Exclusion List or List of Excluded Individuals & Entities (LEIE). Most people already know that if a person or entity commits Medicare fraud they will go on the exclusion list, but many pharmacy owners have been wondering, “What else might someone do to get on that list?” We’ve compiled a few ways to stay off the OIG Naughty List, aka the OIG Exclusion List.

Read More [fa icon=long-arrow-right"]

Podcast: Competitive Bid, What does that Mean to Me

[fa icon="calendar'] Wed, Dec 12, 2018 / by Becky Templeton posted in Pharmacy

[fa icon="comment"] 0 Comments

Did you hear that Competitive Bidding is being eliminated and everyone can start doing DME again?  While it’s not being totally eliminated, Competitive Bidding will be suspended nationwide from 1/1/2019-12/31-2020, while a new program is being prepared.  Many pharmacies will be able to start dispensing things previously deemed ineligible if the pharmacy was in one of those competitive bidding zones.
Read More [fa icon=long-arrow-right"]
Free Immunization Pharmacy Guide

Subscribe to Email Updates

Popular Posts

Recent Posts